Blood Test Could Lead to Cystic Fibrosis Treatment Tailored to Each Patient

Newswise imageResearchers at Stanley Manne Children’s Research Institute at Ann & Robert H. Lurie Children’s Hospital of Chicago, and colleagues, used a blood test and microarray technology to identify distinct molecular signatures in children with cystic fibrosis. These patterns of gene expression ultimately could help predict disease severity and treatment response, and lead to therapies tailored to each patient’s precise biology.

Source link

Related posts

Hydroxyurea Use for Sickle Cell Disease Among Medicaid-Enrolled Children


High Nicotine Concentrations Delivered by ‘Pod Mods’


Children's Health


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy